-
End Stage Renal Disease (ESRD) Patients' Willingness to Accept Risks to Living Kidney Donors.
-
End Stage Renal Disease Patients Have a Skewed T Cell Receptor Vbeta Repertoire.
-
End-Stage Renal Disease Does Not Impair the Large-Scale Generation of Potent Alloantigen-Specific Regulatory T Cells for Immunotherapy.
-
Endoscopic Polydimethylsiloxane Injection in Prevention of Recurrent Graft Pyelonephritis for Transplanted Kidney with Vesicoureteral Reflux.
-
Engineering a “Hybrid Thymus” to Promote Transplant Tolerance.
-
Enhanced Activation of Hemostasis During Kidney Transplantation in Patients on Dialysis Compared to Pre-Emptively Transplanted Patients.
-
Enhanced IL-6 Production Impedes Transplant Tolerance Induction in Lupus-Prone Mice.
-
Enhanced Natural Killer Responsiveness Is a Potent Cytotoxic Mechanism Associating to Kidney Allograft Dysfunction and Pathogenic Effects of Donor-Specific Antibodies (DSA).
-
Enhanced Recovery After Kidney Transplantation: 48 Hour Length of Stay in Living and Deceased Donor Transplant Recipients.
-
Eomesodermin Expression by CD8+ Alloreactive T Cells in Human and Nonhuman Primate Allograft Recipients.
- « Previous Page
- 1
- …
- 53
- 54
- 55
- 56
- 57
- …
- 180
- Next Page »